157
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Recurrent Anterior Non-necrotizing Scleritis as an Adverse Event of ChAdOx1 nCoV-19 (Vaxzevria) Vaccine

, MD, FEBO, , MD, , MD, , MD, PhD & , MD, PhD
Pages 1247-1249 | Received 02 Jul 2021, Accepted 11 Feb 2022, Published online: 08 Apr 2022

References

  • Malas MB, Naazie IN, Elsayed N, Mathlouthi A, Marmor R, Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis. EClinicalMedicine [Internet]. December 1, 2020 Accessed June 18, 2021;29. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30383-7/abstract
  • Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. April 2020;18(4):844–847. doi:10.1111/jth.14768.
  • Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. June 2020;104(6):748–751. doi:10.1136/bjophthalmol-2020-316304.
  • Zhang X, Chen X, Chen L, et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf. July 2020;18(3):360–362. doi:10.1016/j.jtos.2020.03.010.
  • Otaif W, Al Somali AI, Al Habash A. Episcleritis as a possible presenting sign of the novel coronavirus disease: a case report. Am J Ophthalmol Case Rep. 2020;20:100917. doi:10.1016/j.ajoc.2020.100917.
  • Mangana CM, Kargacin AB, Barraquer RI. Episcleritis as an ocular manifestation in a patient with COVID-19. Acta Ophthalmol (Copenh). 2020;98:e1056–7.
  • Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet Lond Engl. January 9, 2021;397(10269):99–111.
  • Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1nCov-19 vaccination. N Engl J Med [Internet]. April 9, 2021 Accessed June 18, 2021;384(22):2092–2101. doi:10.1056/NEJMoa2104840
  • de la Maza MS, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. Feb 1, 1994;101(2):389–396. doi:10.1016/S0161-6420(94)31325-X.
  • Fong LP, de la Maza MS, Rice BA, Kupferman AE, Foster CS. Immunopathology of Scleritis. Ophthalmology. April 1, 1991;98(4):472–479. doi:10.1016/S0161-6420(91)32280-2.
  • Brawman-Mintzer O, Mondino BJ, Mayer FJ. Distribution of complement in the sclera. Invest Ophthalmol Vis Sci. October 1, 1989;30(10):2240–2244.
  • Naseri A, Good WV, and Cunningham ET Jr . Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination. Am J Ophthalmol. March, 2003;135(3):415–7. doi:10.1016/s0002-9394(02)01957-8.
  • Thurairajan G, Hope-Ross MW, Situnayake RD, Murray PI. Polyarthropathy, orbital myositis and posterior scleritis: an unusual adverse reaction to influenza vaccine. Rheumatology. January 1, 1997;36(1):120–123. doi:10.1093/rheumatology/36.1.120.
  • Menni C, Klaser K, May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis [Internet]. April 27, 2021 Accessed June 19, 2021;21(7):939–949. doi:10.1016/S1473-3099(21)00224-3
  • Keller J, Torres-Torres R, Sainz de la Maza M. Anterior scleritis and celiac disease: a proposed association. OculImmunolInflamm. October 2013;21(5):410–412.
  • Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. ClinPharmacolTher. August 1981;30(2):239–245.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.